When was Helix Biostructures founded?

Helix Biostructures was founded in 2017.

Where is Helix Biostructures located?

Helix Biostructures is headquartered in Columbus, United States.

How many employees does Helix Biostructures have?

As of Jun 30, 2026, the latest employee count at Helix Biostructures is 18.

Is Helix Biostructures a funded company?

Helix Biostructures is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Helix Biostructures rank among its competitors?

Helix Biostructures ranks 241st amongst 831 active competitors, of which 56 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Alloy Therapeutics, which secured $40M in Mar, 2026.

Who are the top competitors of Helix Biostructures?

Helix Biostructures' top competitors include Alloy Therapeutics, Maiva Pharma and Simulations Plus. Among them, Alloy Therapeutics secured the most recent funding round in March, 2026.

Helix Biostructures - 2026 Company Profile & Competitors

Helix Biostructures' employee count trend

Helix Biostructures has 18 employees as of Jun 26. Here is Helix Biostructures's employee count trend over the years:

Employee count trend for Helix Biostructures

Uncover Helix Biostructures' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Helix Biostructures include Alloy Therapeutics, Maiva Pharma and Simulations Plus. Here is the list of Top 10 competitors of Helix Biostructures, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Alloy Therapeutics 2017, Lexington (United States), Series E	Provider of drug discovery services	$157M	8VC, Mubadala & 11 others	63/100
2nd	Maiva Pharma 1996, Hosur (India), Late Stage	Manufacturer of sterile injectables	$125M	Nhpea V Spear, Nano Vista & 25 others	61/100
3rd	Simulations Plus 1996, Lancaster (United States), Public	Developer of modeling and simulation software and consulting services provider	-	FDA, NIH & 1 others	60/100
4th	Manifold Bio 2018, United States, Series A	Developer of tissue-targeted therapeutics using in vivo screening and AI design	$78.2M	Playground Global, Triatomic & 8 others	54/100
5th	CILcare 2014, Montpellier (France), Series A	Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus	$42.3M	Shionogi, Galia Gestion & 5 others	53/100
6th	VelaVigo 2021, Shanghai (China), Seed	Biotechnology research company developing biological drugs	$160M	Shunwei Capital, Panacea Venture & 17 others	53/100
7th	ArcaScience 2018, Paris (France), Seed	Developer of AI models for patient-centric insights in drug development	$7M	The Moon Venture, Kima Ventures & 5 others	52/100
8th	Viva Biotech 2006, Shanghai (China), Public	Research services focused on drug discovery and development	-	Temasek, Spinnotec & 3 others	51/100
9th	Arctoris 2016, Abingdon (United Kingdom), Seed	Provider of automated wet lab biology research and data generation services	$3.93M	RT, TD Veen & 7 others	51/100
10th	Superluminal Medicines 2022, Boston (United States), Series A	Generative biological and chemical company focused on drug discovery	$158M	RA Capital Management, Insight Partners & 5 others	50/100
241st	Helix Biostructures 2017, Columbus (United States), Unfunded	Provider of structural biology and medicinal chemistry services	-	-	20/100